KMD Bioscience specializes in a range of advanced biotechnological platforms aimed at enhancing drug discovery and development, particularly in the field of antibody research. Their offerings include a comprehensive yeast display platform that allows for the efficient expression and screening of antibodies. This technology integrates antibody gene fragments onto the surface of yeast cells, enabling high-throughput screening for antibodies with high affinity and specificity. The platform is designed to support various applications, including the development of CAR-T and CAR-NK cell therapies, and is complemented by services such as yeast library construction and screening, which ensure a diverse and high-quality antibody library for research and clinical applications.

In addition to their yeast display technology, KMD Bioscience provides a suite of services including antibody humanization, cell immortalization, and aptamer synthesis. Their protein platform offers services for protein expression, purification, and labeling, while their rabbit single B cell screening service focuses on the development of high-quality antibodies. The company also supplies small molecule products and animal disease detection solutions, demonstrating a broad commitment to supporting pharmaceutical research and innovation. With a focus on high-quality contract research organization (CRO) services, KMD Bioscience aims to facilitate advancements in pharmaceutical technology and improve outcomes in drug development.

China

KMD Bioscience is a biotech company located in Tianjin, China. Our CRO services&products cover antibody engineering(recombinant antibodyproduction, antibody sequencing&purification), protein production, expressionand purification and other services related to phage display, stable cell lineconstructionand peptide.

KMD Bioscience

Company Details